Lactogens protect rodent and human beta cells against glucolipotoxicity-induced cell death through Janus kinase‐2 (JAK2)/signal transducer and activator of transcription-5 (STAT5) signalling

[1]  M. Prentki,et al.  Type 2 diabetes across generations: from pathophysiology to prevention and management , 2011, The Lancet.

[2]  A. Gilmore,et al.  Bcl-2 proteins and mitochondria--specificity in membrane targeting for death. , 2011, Biochimica et biophysica acta.

[3]  M. Sogayar,et al.  Recombinant human prolactin promotes human beta cell survival via inhibition of extrinsic and intrinsic apoptosis pathways , 2011, Diabetologia.

[4]  N. G. Kondegowda,et al.  Growth Factor Mediated Regulation of Beta Cell Survival , 2010 .

[5]  A. F. Stewart,et al.  Parathyroid Hormone–Related Protein Enhances Human β-Cell Proliferation and Function With Associated Induction of Cyclin-Dependent Kinase 2 and Cyclin E Expression , 2010, Diabetes.

[6]  S. Messinger,et al.  Prolactin Supplementation to Culture Medium Improves &bgr;-Cell Survival , 2010, Transplantation.

[7]  J. Cross,et al.  Prolactin receptor is required for normal glucose homeostasis and modulation of beta-cell mass during pregnancy. , 2009, Endocrinology.

[8]  J. Rehfeld,et al.  Pregnancy-Induced Rise in Serum C-Peptide Concentrations in Women With Type 1 Diabetes , 2009, Diabetes Care.

[9]  M. Cnop.  Fatty acids and glucolipotoxicity in the pathogenesis of Type 2 diabetes. , 2008, Biochemical Society transactions.

[10]  R. Robertson,et al.  Glucolipotoxicity: fuel excess and beta-cell dysfunction. , 2008, Endocrine reviews.

[11]  P. A. Friedman,et al.  Protein Kinase C-ζ Activation Markedly Enhances β-Cell Proliferation , 2007, Diabetes.

[12]  K. Takane,et al.  Lactogens Promote Beta Cell Survival through JAK2/STAT5 Activation and Bcl-XL Upregulation* , 2007, Journal of Biological Chemistry.

[13]  Ji-yeon Lee,et al.  The transcription factors Stat5a/b are not required for islet development but modulate pancreatic beta-cell physiology upon aging. , 2007, Biochimica et biophysica acta.

[14]  R. Robertson,et al.  Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in Type 2 diabetes , 2007, Cell Biochemistry and Biophysics.

[15]  Ying-Chu Lee,et al.  STAT5 Activity in Pancreatic β-Cells Influences the Severity of Diabetes in Animal Models of Type 1 and 2 Diabetes , 2006, Diabetes.

[16]  M. Prentki,et al.  Islet beta cell failure in type 2 diabetes. , 2006, The Journal of clinical investigation.

[17]  I. Cózar-Castellano,et al.  Growth factors and beta cell replication. , 2006, The international journal of biochemistry & cell biology.

[18]  J. Pierre,et al.  JAK/STAT signal transduction: regulators and implication in hematological malignancies. , 2006, Biochemical pharmacology.

[19]  R. Vasavada,et al.  Characterization of mice doubly transgenic for parathyroid hormone-related protein and murine placental lactogen: a novel role for placental lactogen in pancreatic beta-cell survival. , 2004, Diabetes.

[20]  M. Pretolani,et al.  Glucocorticoid-induced apoptosis in human eosinophils: Mechanisms of action , 2003, Apoptosis.

[21]  M. Prentki,et al.  Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. , 2003, Endocrinology.

[22]  T. Toyama,et al.  Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells , 2003, Oncogene.

[23]  Robert A. Rizza,et al.  β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.

[24]  L. Holmes,et al.  Declining insulin requirement in the late first trimester of diabetic pregnancy. , 2001, Diabetes care.

[25]  G. Melino,et al.  High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. , 2001, Diabetes.

[26]  L. Hennighausen,et al.  Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly. , 2000, Development.

[27]  F. Talamantes,et al.  Targeted Expression of Placental Lactogen in the Beta Cells of Transgenic Mice Results in Beta Cell Proliferation, Islet Mass Augmentation, and Hypoglycemia* , 2000, The Journal of Biological Chemistry.

[28]  A. Weinhaus,et al.  Dexamethasone counteracts the effect of prolactin on islet function: implications for islet regulation in late pregnancy. , 2000, Endocrinology.

[29]  E. Andreu,et al.  Blockade of the Bcr-Abl Kinase Activity Induces Apoptosis of Chronic Myelogenous Leukemia Cells by Suppressing Signal Transducer and Activator of Transcription 5–Dependent Expression of Bcl-XL , 2000, The Journal of experimental medicine.

[30]  E. Ziv,et al.  Nutritionally Induced Insulin Resistance and Receptor Defect Leading to β‐Cell Failure in Animal Models , 1999, Annals of the New York Academy of Sciences.

[31]  P. Kelly,et al.  From the molecular biology of prolactin and its receptor to the lessons learned from knockout mice models. , 1999, Genetic analysis : biomolecular engineering.

[32]  F. Prósper,et al.  Erythropoietin Can Induce the Expression of Bcl-xLthrough Stat5 in Erythropoietin-dependent Progenitor Cell Lines* , 1999, The Journal of Biological Chemistry.

[33]  F. Gouilleux,et al.  IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line , 1999, Oncogene.

[34]  E. Cerasi,et al.  Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. , 1999, Diabetes.

[35]  R. Unger,et al.  Fatty acid-induced β cell apoptosis: A link between obesity and diabetes , 1998 .

[36]  K. Polonsky,et al.  Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat. , 1998, Diabetes.

[37]  P. Kelly,et al.  Ontogenesis of prolactin receptors in the human fetus in early gestation. Implications for tissue differentiation and development. , 1997, The Journal of clinical investigation.

[38]  R. Sorenson,et al.  Prolactin receptors and JAK2 in islets of Langerhans: an immunohistochemical analysis. , 1995, Endocrinology.

[39]  J. Nielsen,et al.  Effects of sex and pregnancy hormones on growth hormone and prolactin receptor gene expression in insulin-producing cells. , 1993, Endocrinology.

[40]  P. Lacy,et al.  Effect of homologous placental lactogens, prolactins, and growth hormones on islet B-cell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet function during pregnancy. , 1993, Endocrinology.

[41]  R. Puukka,et al.  Residual B-Cell Function and Glycaemic Control in Diabetic Pregnancy , 1986, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[42]  K. Hummel,et al.  The Influence of Genetic Background on the Expression of Mutations at the Diabetes Locus in the Mouse: III. Effect of H-2 Haplotype and Sex , 1981, Diabetes.

[43]  D. Coleman,et al.  Symposium IV: Diabetic syndrome in animals. Influence of genetic background on the expression of mutations at the diabetes locus in the mouse. II. Studies on background modifiers. , 1975, Israel journal of medical sciences.

[44]  G. Ferbeyre,et al.  The role of Stat5 transcription factors as tumor suppressors or oncogenes. , 2011, Biochimica et biophysica acta.

[45]  P. Butler,et al.  Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2 diabetes. , 2006, ILAR journal.

[46]  S. Yagihashi,et al.  Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients , 2002, Diabetologia.

[47]  F. Talamantes.  Structure and regulation of secretion of mouse placental lactogens. , 1990, Progress in clinical and biological research.

[48]  P. Kelly,et al.  Printed in U.S.A. Copyright © 2002 by The Endocrine Society Targeted Deletion of the PRL Receptor: Effects on Islet Development, Insulin Production, and Glucose Tolerance , 2022 .